当前位置:首页 - 行情中心 - 人福医药(600079) - 财务分析 - 现金流量表

人福医药

(600079)

  

流通市值:314.81亿  总市值:332.97亿
流通股本:15.43亿   总股本:16.32亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金5,303,884,585.0324,143,262,438.2717,907,290,319.5811,932,006,456.05
收到的税费返还26,430,476.8195,326,630.1775,388,365.6143,864,455.51
收到其他与经营活动有关的现金117,301,969.89458,703,965.73326,007,646.44171,613,296.28
经营活动现金流入的平衡项目0000
经营活动现金流入小计5,447,617,031.7324,697,293,034.1718,308,686,331.6312,147,484,207.84
购买商品、接受劳务支付的现金2,749,877,070.7812,257,696,998.428,955,098,813.885,976,915,872.2
支付给职工以及为职工支付的现金1,254,794,780.053,370,452,761.582,716,275,940.471,939,667,603.16
支付的各项税费502,050,642.771,967,699,324.781,522,844,139.221,052,763,416.15
支付其他与经营活动有关的现金1,277,674,178.764,937,178,889.93,621,788,984.982,332,259,928.14
经营活动现金流出的平衡项目0000
经营活动现金流出小计5,784,396,672.3622,533,027,974.6816,816,007,878.5511,301,606,819.65
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-336,779,640.632,164,265,059.491,492,678,453.08845,877,388.19
二、投资活动产生的现金流量:
收回投资收到的现金373,391.2856,106,178.3653,144,375.55-
取得投资收益收到的现金777,90031,340,550.0429,173,034.9628,122,023.69
处置固定资产、无形资产和其他长期资产收回的现金净额5,179,210.4136,183,79431,551,767.1723,904,289
处置子公司及其他营业单位收到的现金净额2,900,000220,619,202.5278,541,579.19-
收到的其他与投资活动有关的现金-138,687,50076,937,50052,187,500
投资活动现金流入的平衡项目0000
投资活动现金流入小计9,230,501.69482,937,224.92269,348,256.87104,213,812.69
购建固定资产、无形资产和其他长期资产支付的现金249,050,876.061,020,943,995.37794,874,603.43538,506,715.99
投资支付的现金-6,750,0005,000,0005,000,000
取得子公司及其他营业单位支付的现金-53,039,279.9253,231,097.1952,949,462.47
支付其他与投资活动有关的现金-144,229,056.7104,103,278.790,000,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计249,050,876.061,224,962,331.99957,208,979.32686,456,178.46
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-239,820,374.37-742,025,107.07-687,860,722.45-582,242,365.77
三、筹资活动产生的现金流量:
吸收投资收到的现金-18,010,0008,540,0005,540,000
其中:子公司吸收少数股东投资收到的现金-18,010,0008,540,0005,540,000
取得借款收到的现金2,257,490,0009,348,149,069.226,570,205,069.224,765,780,000
收到其他与筹资活动有关的现金77,739,393.43494,776,099.48318,656,657.15238,984,510.19
筹资活动现金流入平衡项目0000
筹资活动现金流入小计2,335,229,393.439,860,935,168.76,897,401,726.375,010,304,510.19
偿还债务支付的现金1,913,455,029.429,440,221,160.496,383,972,622.024,480,313,709.3
分配股利、利润或偿付利息支付的现金111,452,680.241,390,240,847.571,102,039,051.241,001,099,366.14
其中:子公司支付给少数股东的股利、利润23,164,378.32120,931,806.9110,696,241.2499,515,741.24
支付其他与筹资活动有关的现金129,147,679.63528,470,522.67375,461,722.67269,088,092.04
筹资活动现金流出平衡项目0000
筹资活动现金流出小计2,154,055,389.2911,358,932,530.737,861,473,395.935,750,501,167.48
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额181,174,004.14-1,497,997,362.03-964,071,669.56-740,196,657.29
四、汇率变动对现金及现金等价物的影响6,805,021.75-23,866,875.3-42,337,124.548,783,510
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-388,620,989.11-99,624,284.91-201,591,063.47-467,778,124.87
加:期初现金及现金等价物余额2,890,820,258.262,990,444,543.172,990,444,543.172,990,444,543.17
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,502,199,269.152,890,820,258.262,788,853,479.72,522,666,418.3
补充资料:
净利润-1,778,342,930.44-1,455,630,352.46
资产减值准备-393,861,278.28-4,036,730.68
固定资产和投资性房地产折旧-759,401,492.1-360,637,983.83
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-759,401,492.1-360,637,983.83
无形资产摊销-242,492,192.99-103,175,565.52
长期待摊费用摊销-17,543,227.89-8,174,536.25
处置固定资产、无形资产和其他长期资产的损失-4,472,024.18-532,848.97
固定资产报废损失-11,821,590.41-495,152.98
公允价值变动损失--112,716,765.01-5,660,932.78
财务费用-336,704,934.23-170,828,359.45
投资损失--143,838,770.49--35,124,357.4
递延所得税-658,265.46--9,396,133.99
其中:递延所得税资产减少--6,631,221.33--2,140,670.99
递延所得税负债增加-7,289,486.79--7,255,463
存货的减少--459,024.88--221,380,354.87
经营性应收项目的减少--764,553,123.28--699,684,462.1
经营性应付项目的增加--679,476,910.52--350,421,266.62
其他-13,273,361.22-11,122,999.48
现金的期末余额-2,890,820,258.26-2,522,666,418.3
减:现金的期初余额-2,990,444,543.17-2,990,444,543.17
公告日期2025-04-292025-04-292024-10-302024-07-27
审计意见(境内)带强调事项段的无保留意见
TOP↑